Does Diabetes Always Confer Coronary Heart Disease Risk Equivalent to a Prior Myocardial Infarction? Implications for prevention

被引：12

作者：

Boyko, Edward J. ^{[1
,2
]}

Meigs, James B. ^{[3
]}

机构：

[1] VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA

[2] Univ Washington, Dept Med, Seattle, WA 98195 USA

[3] Harvard Univ, Sch Med, Div Gen Med, Boston, MA USA

来源：

DIABETES CARE | 2011年 / 34卷 / 03期

关键词：

SCIENTIFIC STATEMENT; TYPE-2; INTERVENTION; ASSOCIATION; ASPIRIN; PEOPLE;

D O I：

10.2337/dc10-1958

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：782 / 784

页数：3

共 17 条

[1] Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
Bulugahapitiya, U.
Siyambalapitiya, S.
Sithole, J.
Idris, I.
[J]. DIABETIC MEDICINE, 2009, 26 (02) : 142 - 148
[2] Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Burgess, David C.
Hunt, David
Li, LiPing
Zannino, Diana
Williamson, Elizabeth
Davis, Timothy M. E.
Laakso, Markku
Kesaniemi, Y. Antero
Zhang, Jun
Sy, Raymond W.
Lehto, Seppo
Mann, Stewart
Keech, Anthony C.
[J]. EUROPEAN HEART JOURNAL, 2010, 31 (01) : 92 - 99
[3] Buse JB, 2007, DIABETES CARE, V30, P162, DOI [10.2337/dc07-9917, 10.1161/CIRCULATIONAHA.106.179294]
[4] What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits)
Cohen, Joshua T.
Neumann, Peter J.
[J]. HEALTH AFFAIRS, 2007, 26 (03) : 636 - 646
[5] Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
[6] Presenting risk information - A review of the effects of "framing'' and other manipulations on patient outcomes
Edwards, A
Elwyn, G
Covey, J
Matthews, E
Pill, R
[J]. JOURNAL OF HEALTH COMMUNICATION, 2001, 6 (01) : 61 - 82
[7] Long-Term Cardiovascular Risk in Type 2 Diabetic Compared With Nondiabetic First Acute Myocardial Infarction Patients A population-based cohort study in southern Europe
Francisco Cano, J.
Baena-Diez, Jose M.
Franch, Josep
Vila, Joan
Tello, Susana
Sala, Joan
Elosua, Roberto
Marrugat, Jaume
[J]. DIABETES CARE, 2010, 33 (09) : 2004 - 2009
[8] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
Haffner, SM
Lehto, S
Rönnemaa, T
Pyörälä, K
Laakso, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) : 229 - 234
[9] 10-year follow-up of intensive glucose control in type 2 diabetes
Holman, Rury R.
Paul, Sanjoy K.
Bethel, M. Angelyn
Matthews, David R.
Neil, H. Andrew W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) : 1577 - 1589
[10] Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine
Kalow, W.
[J]. PHARMACOGENOMICS JOURNAL, 2006, 6 (03) : 162 - 165

← 1 2 →